Who Paid My Doc
Interchangeability Study - ABP 654
Research payments
$5,400,368
Through program year 2021, $5,400,368 in research payments was reported against Interchangeability Study - ABP 654, across 115 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $5,400,368 | 115 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- James Coggi West Des Moines, IA Named on 4 payments
- Dowling Stough Hot Springs, AR Named on 4 payments
- Rosalyn George Wilmington, NC Named on 4 payments
- Edward Lain Austin, TX Named on 4 payments
- Sunil Dhawan Fremont, CA Named on 4 payments
- Jerry Bagel East Windsor, NJ Named on 4 payments
- Mark Lee San Antonio, TX Named on 4 payments
- Patricia Lee Webster, TX Named on 4 payments
- Andrew Blauvelt Portland, OR Named on 4 payments
- Catherine Pointon Charlotte, NC Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.